386th MEETING OF THE MEDICAL SCHOOL COUNCIL
3 p.m., Wednesday, December 9, 2009
School of Medicine Administration, Board Room 103
PRESENT: Drs. Abuav, Ahn, Armstrong, Barker, Carroll, Comfort, Cooke, Fine, Goldstein, Gottesman, Herman, Ishii, Matunis, Nyhan, Shapiro, Williams, Wolfgang, Wong, Messrs. Mandell and David Rini (for Fairman), Ruzevick, Ms. Foy
ABSENT: Drs. Bastian, Brayton, Chou, Chuck, Cromwell, Green, Leahy, McCarthy, Meffert, Molinaro, Pavlovich, Reading, Regan, Resar, Schramm, Stivers, Tis, Tufaro, Mr. Bicket, Mss. Matthys and Nguyen .
GUESTS: Drs. Clark and Nelson
The minutes of the November 11, 2009 meeting were approved.
II. Chair’s Report – Dr. Armstrong
Dr. Armstrong reminded the Medical School Council that the January meeting has been rescheduled to January 6, 2010 in order to accommodate Provost Minor’s schedule.
Agenda items for the February meeting were requested.
III. Update on International Sites- Dr. Michael Clark, Medical Director, Global Services, Johns Hopkins International
Dr. Clark presented an overview of Johns Hopkins International (JHI), a limited liability for-profit corporation created to facilitate Johns Hopkins Medicine’s global development in research, education, and clinical services. The organization began in 1999 with 80 employees and has grown to 150 employees today.
The major service lines are patient services, global services, and global ventures.
Patient Services coordinates care for 3,000 international patients each year resulting in 36,500 appointments and 900 admissions. Twenty languages are spoken by international staff and interpretation serves are available 24/7. In addition, Johns Hopkins USA coordinates care for 4,000 out-of-state patients each year, scheduling 11,000 appointments, resulting in 400+ admissions. Dedicated staff are available to provide an array of patient services, guest services, and clinical services. Johns Hopkins International Community Outreach provides interpretive services to Johns Hopkins Medicine hospitals as well as other services to the Hispanic community and other non-English speaking patients. Philanthropy for international patients has exceeded $90 million over the last five years.
Global Services facilitates international management and consulting relationships (IT, operational, academic and clinical programs) to improve health care globally. Last year over 350 faculty and staff participated in consulting activities in Baltimore and abroad. There are relationships with health care and corporate partners in the Middle East, Latin America, Europe, Asia, and North America.
Johns Hopkins International manages and/or administers day-to-day operations to hospitals in many countries including the United Arab Emirates, Singapore, Turkey, Chile, and the Republic of Trinidad and Tobago.
The Global Ventures division serves as a resource to faculty and departments in their international ventures.
In summarizing the accomplishments of JHI, Dr. Clark noted a 28% increase in international outpatient encounters in FY08, a 35% increase in limited English proficient domestic patients, and a downstream revenue growth from $83 million in FY07 to $98 million in FY08.
After responding to questions from the council, Dr. Armstrong thanked Dr. Clark for his presentation.
IV. Update on the Status of the Cancer Center- Dr. William Nelson, Director of the Sidney Kimmel Comprehensive Cancer Center
As background, Dr. Nelson reported a 14% decrease in U.S. cancer mortality for all cancer since 1991. He noted about one in two men and one in three women will develop cancer in their lifetime and 77% of all cancer will be diagnosed after age 55. The cost of treating cancer in the U.S. in 1997 was $104 billion and $206 billion in 2006.
The mapping/sequencing of the human genome revolutionized cancer genetics and epidemiology and provided unprecedented opportunities for the discovery of new approaches to cancer treatment and prevention. With new tools and technology, the approach to treatment is moving from treating disease to intervening before symptoms appear. Current challenges of drug discovery and development were discussed. It costs $1 billion and ten years to bring a drug to market with most clinical trials failing in Phase III. Dr. Nelson reviewed the historical development pathways for anti-cancer drugs and discussed the new development pathway based on emerging technology from the human genome project. The Cancer Center is poised to lead the transformation of cancer care to personalized cancer medicine. Some 26 departments and 220 faculty are represented in the Cancer Center. Sponsored funding is $180 million a year with a large fraction of patients in clinical trials. The center sees over 7,000 new patients a year and the inpatient facility runs at 98% occupancy.
Dr. Nelson spoke to the increased demand for cancer care in both the United States and in the region. Challenges for the Cancer Center include competition for patients in this region, limited current capacity to deliver care, and management of growth to promote research, teaching, and patient care.
Dr. Nelson outlined plans for creating a better “Front Door” to the Cancer Center by creating multidisciplinary approaches to clinical care and patient centered services.
After responding to questions, Dr. Armstrong thanked Dr. Nelson for his presentation.
V. Other Business
There being no further business this meeting was adjourned at 4:30 p.m.
Mary E. Foy
Future Medical School Council meetings:
All meetings will be held in the School of Medicine Board Room (SOM 103), 3:00 to 5:00 p.m.
Feb. 17, 2010
Mar. 24, 2010
Apr. 21, 2010
May 26, 2010
June 23, 2010